-
Mashup Score: 2
expert roundtables by David Scott Miller, MD, FACOG, FACS; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Pamela T. Soliman, MD, MPH Following surgery for intermediate- to high-risk endometrial cancer, clinicians and patients carefully weigh the risks and benefits of adjuvant therapies. Tumor characteristics used to guide treatment selection for advanced and recurrent endometrial cancer may eventually have a role in the selection of adjuvant therapy. “I tell patients that we could potentially reduce the
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Expert Roundtables Podcast: The Use of Biomarkers in the Management of Endometrial Cancer - Expert Perspectives - 12 day(s) ago
expert roundtables by David Scott Miller, MD, FACOG, FACS; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Pamela T. Soliman, MD, MPH When combined with histological characteristics, molecular biomarkers support a personalized treatment approach for endometrial cancer. Selecting treatments based on a patient’s biomarkers may help to not only maximize treatment benefits but also prevent treatment-related toxicities in patients whose endometrial cancer is unlikely to respond to the therapies. Our featured
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet-
Expert Roundtables Podcast: The Use of #Biomarkers in the Management of #EndometrialCancer with @PamSolimanMD. From @eponcology . #gyncsm https://t.co/W3mLEmVSd6
-
-
Mashup Score: 4
expert roundtables by David Scott Miller, MD, FACOG, FACS; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Pamela T. Soliman, MD, MPH Long-term survival in patients with endometrial cancer has increased with our understanding of the disease and its subtypes. Understanding predictive factors for survival in patients with endometrial cancer can help clinicians match each patient with the best treatment option. What are the best predictors of survival in patients with endometrial cancer? “As a result of The
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet-
Predictors of Long-term #Survival in #EndometrialCancer. From Expert Perspectives in Oncology (@eponcology) with Drs. Alexander Olawaiye and Pamela T. Soliman (@PamSolimanMD). #tcga https://t.co/TgWXIIu8RO
-
-
Mashup Score: 9State-of-the-Art Management of Advanced or Recurrent Endometrial Cancer - Expert Perspectives - 1 year(s) ago
Standard options to treat primary advanced or recurrent endometrial cancer after failure of platinum-based chemotherapy have been limited. The emergence of immunotherapy and targeted therapies in this space has been encouraging, and researchers are aiming to build on these initial successes.
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet-
State-of-the-Art Management of Advanced or Recurrent #EndometrialCancer. With Drs. Alex Olawaiye & @PamSolimanMD from @eponcology. https://t.co/nREqK0jf7q #pembrolizumab #lenvatinib #her2 #gyncsm @KEYTRUDA @Lenvima_HCP
-
-
Mashup Score: 7
Some patients with endometrial cancer are deemed medically inoperable due to factors such as advanced age and comorbidities that increase perioperative risk. For such patients, definitive radiation therapy is an option that can result in favorable local control and improved survival outcomes.
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet-
Radiation Therapy for Medically Inoperable Endometrial Cancer from @eponcology https://t.co/Hp2w4qisvr #gyncsm #endometrialcancer #radiationtherapy
-
Adjuvant Treatment for Endometrial Cancer with Drs. Alex Olawaiye & @PamSolimanMD . From @eponcology. #gyncsm #endometrialcancer #adjuvant https://t.co/OrZsHeBNjL